Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells (Q40661639)

22 September 2017

title

Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells (English)

1 reference

22 September 2017

Andreas Heiske

1

1 reference

22 September 2017

Jutta Jesberg

series ordinal

2

1 reference

22 September 2017

Jürgen-Christian Krieg

series ordinal

3

1 reference

22 September 2017

Helmut Vedder

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

6 September 2002

1 reference

22 September 2017

published in

Neuropsychopharmacology

1 reference

22 September 2017

volume

28

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

807-817

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300056

22 September 2017

exact match

0 references

cites work

The role of corticotropin-releasing factor in depression and anxiety disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Gene regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Steroid hormone receptors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Evidence for an immune response in major depression: a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

The monocyte-T-lymphocyte hypothesis of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Inflammatory markers in major depression and melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Modulation of cellular expression of glucocorticoid receptor and glucocorticoid response element-DNA binding in rat brain during alcohol drinking and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Ethanol-mediated regulation of transcription factors in immunocompetent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Cytokine production and treatment response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Corticosteroid receptor function is decreased in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Effects of chronic antidepressant treatment on the hypothalamic-pituitary-adrenal axis of Wistar rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Major depressive disorder is associated with elevated monocyte counts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300056

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300056

1 reference

Dimensions Publication ID

22 September 2017

1027569151

0 references

1 reference